Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1791-1800 of 2869 for cancer

Edit search filters
  1. A Study Of Rociletinib (CO-1686) For Patients With A Mutant Form Of Non-Small Cell Lung Cancer.

    Scottsdale/Phoenix, AZ

  2. Radiation Therapy With Durvalumab Or Cetuximab To Treat Patients With Locoregionally Advanced Head And Neck Cancer Who Cannot Take Cisplatin

    Rochester, MN

  3. FES PET/CT In Predicting Response In Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

    Rochester, MN

  4. Intensity-Modulated Radiation Therapy And Paclitaxel With Or Without Pazopanib Hydrochloride In Treating Patients With Anaplastic Thyroid Cancer

    Jacksonville, FL, Rochester, MN

  5. Gemcitabine Hydrochloride Alone Or With M6620 In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Rochester, MN

  6. A Study Comparing Vaccinia Virus Based Immune System Therapy Plus Sorafenib Versus Sorafenib Alone To Treat Liver Cell Cancer

    Scottsdale/Phoenix, AZ

  7. Study Of TH-302 Or Placebo In Combination With Pemetrexed In Patients With Non-squamous Non-small Cell Lung Cancer

    Rochester, MN

  8. PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine In Subjects With Stage IV Untreated Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  9. Olaparib And Atezolizumab Either Alone Or In Combination In Treating Patients With Stage III-IV Triple Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Maintenance Chemotherapy With Or Without Stereotactic Body Radiation Therapy In Treating Patients With Stage IV Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer